Is the Metabolism of Alfentanil Subject to Debrisoquine Polymorphism? A Study Using Human Liver Microsomes-Reference-Cited by-同舟云学术

Is the Metabolism of Alfentanil Subject to Debrisoquine Polymorphism? A Study Using Human Liver Microsomes

Published:1988-10-01 Issue:4 Volume:69 Page:535-540
ISSN:0003-3022
Container-title:Anesthesiology
language:en
Short-container-title:

Author:

Lavrijsen Karel L. M.¹,Van Houdt Jos M. G.²,Van Dyck Dirk M. J.²,Hendrickx Jan J. J. M.²,Woestenborghs Robert J. H.¹,Lauwers William³,Meuldermans Willem E. G.¹,Heykants Joseph J. P.⁴

Affiliation:

1. Group Leader, Department of Drug Metabolism and Pharmacokinetics.

2. Staff Member, Department of Drug Metabolism and Pharmacokinetics.

3. Group Leader, Department of Analytical Research.

4. Director, Department of Drug Metabolism and Pharmacokinetics.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

Link

http://pubs.asahq.org/anesthesiology/article-pdf/69/4/535/316702/0000542-198810000-00013.pdf

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Physiologically Based Pharmacokinetic Model for the Prediction of Gastrointestinal Drug Absorption: Translocation Model;Drug Metabolism and Disposition;2015-01-23

2. Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates – An evaluation and case study using GastroPlus™;European Journal of Pharmaceutical Sciences;2012-09

3. Inhibition and induction of human cytochrome P450 enzymes: current status;Archives of Toxicology;2008-07-11

4. Individualizing analgesic prescription Part I: pharmacogenetics of opioid analgesics;Personalized Medicine;2006-08

5. Pharmacogenetic Determinants of Human Liver Microsomal Alfentanil Metabolism and the Role of Cytochrome P450 3A5;Anesthesiology;2005-03-01